Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, Helios, #05-06, 138667, Singapore; GEA-NUS Pharmaceutical Processing Research Laboratory, Department of Pharmacy, National University of Singapore, 18 Science Drive 4, 117543, Singapore.
Roquette Asia Pacific Pte. Ltd., 11 Biopolis Way, Helios, #05-06, 138667, Singapore.
Int J Pharm. 2024 Jul 20;660:124298. doi: 10.1016/j.ijpharm.2024.124298. Epub 2024 May 31.
One of the most common forms of controlled release technology for oral drug delivery comprises an active ingredient dispersed in a hydrophilic matrix forming polymer such as hydroxypropyl methylcellulose (HPMC), which is tableted via direct compression. However, HPMC may pose problems in direct compression due to its poor flowability. Hence, mannitol syrup was spray-coated over fluidized HPMC particles to produce co-processed HPMC-mannitol at ratios of 20:80, 50:50, and 70:30. Particles of pure HPMC, co-processed HPMC-mannitol, and their respective physical mixtures were evaluated for powder flowability, compression profiles, and controlled release performance. It was found that co-processed HPMC-mannitol consisted of particles with improved flow compared to pure HPMC particles. Sufficiently strong tablets of >2 MPa could be produced at moderate to high compression forces of 150-200 MPa. The dissolution profile could be tuned to obtain desired release profiles by altering HPMC-mannitol ratios. Co-processed HPMC-mannitol offers an interesting addition to the formulator's toolbox in the design of controlled release formulations for direct compression.
一种最常见的口服药物控释技术形式包括将活性成分分散在亲水性基质形成聚合物中,例如羟丙基甲基纤维素(HPMC),通过直接压缩将其制成片剂。然而,由于 HPMC 流动性差,在直接压缩中可能会出现问题。因此,山梨醇糖浆被喷涂在流化的 HPMC 颗粒上,以产生比例为 20:80、50:50 和 70:30 的共处理 HPMC-山梨醇。对纯 HPMC 颗粒、共处理 HPMC-山梨醇及其各自的物理混合物进行粉末流动性、压缩特性和控释性能评估。结果发现,与纯 HPMC 颗粒相比,共处理的 HPMC-山梨醇颗粒具有改善的流动性。在 150-200 MPa 的中等至高压缩力下,可以生产出足够强度的 >2 MPa 的片剂。通过改变 HPMC-山梨醇的比例,可以调整溶出曲线以获得所需的释放曲线。共处理的 HPMC-山梨醇为直接压缩控释制剂设计提供了一种有趣的选择,为配方师提供了更多的工具。